Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA funding

Executive Summary

FY 1991 budget resolution containing $624 mil. for FDA passed by the House of Representatives May 1. The allotment, which is set at the level needed to maintain current services with an update for inflation, does not assume any revenues from user fees. The Senate Budget Committee approved its budget resolution May 2, but did not include a specific FDA figure nor a position on user fees. Thus, those issues would be decided by Appropriations and Labor & Human Resources Committees. Resolution provides a general framework for spending by other congressional panels.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS017373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel